Search results
125 Results for 'James J. Collins'
- Technologies (9)
- Collaborations (1)
- Team (0)
- News (88)
- Pages (0)
- Multimedia (18)
- Publications (0)
- Jobs (0)
- Events (9)
Technologies 9
-
Sugar-to-Fiber Enzyme for Healthier Food
In collaboration with Kraft Heinz, our sugar-to-fiber product can convert sugar in food products into prebiotic fiber in the human gut, reducing the amount of sugar absorbed into the bloodstream without altering the amount of sugar in existing food product recipes. -
Sparkle: Instant Biosensors for Real-Time Imaging
Sparkle is revolutionizing the binder assay industry by harnessing novel chemistry to create instant fluorescent biosensors for a wide variety of uses. -
Engineered Live Biotherapeutic Product (eLBP) to Protect the Microbiome from Antibiotics
eLBP is a safe and cost-effective therapeutic for patients treated with beta-lactam antibiotics that safeguards against the loss of health-essential microbes while preventing the development and spread of antibiotic resistance. -
wFDCF Face Masks: A Wearable COVID-19 Diagnostic
The Problem The COVID-19 pandemic has made it starkly clear that the world lacks rapid, accurate diagnostic tests for pathogens. When patients arrive in a medical facility for treatment, the triage process is hindered by diagnostic tests that are inaccurate or take a long time to produce results. In addition, patients who are asymptomatic and... -
INSPECTR™: Direct-to-Consumer Molecular Diagnostic
INSPECTR™ is a molecular diagnostic platform that combines freeze-dried synthetic gene networks with cell-free expression systems to create novel biosensors that detect and report the presence of a target DNA or RNA molecule without the need for power or lab equipment. This technology was licensed by Wyss startup Sherlock Biosciences in 2019. -
Wearable stochastic resonance technology for supporting neurological function
Accelera has licensed the Wyss Institute’s stochastic resonance technology to develop fully wearable medical devices that support neurological function in patients with cerebral palsy and other conditions.
Collaborations 1
Kraft Heinz PartnershipNews 88
Multimedia 18
-
Audio/PodcastTranslating SynBio with Jim CollinsThe BIOS Podcast by Alix Ventures features experts and thought leaders in healthcare & life sciences. We bring you cutting-edge insights from executives, investors, founders, scientists, academics, and more. BIOS is a community of early stage healthcare and life sciences founders and investors. It is anchored by Alix Ventures, a San Francisco-based venture fund that invests in early stage... -
Video/AnimationeToehold: an RNA-detecting control element for use in RNA therapeutics, diagnostics and cell therapiesThis animation shows an example of an eToehold that detects and signals the presence of a specific viral RNA in a human cell. After the virus has injected its RNA into a host cell, the RNA acts as a “trigger RNA” by binding to a complementary sequence within the eToehold specifically engineered for its detection.... -
Video/AnimationmiSherlock – Detecting COVID-19 Variants from SalivaDespite increasing vaccination rates, new, more-infectious variants of SARS-CoV-2 could prolong the COVID-19 pandemic. Researchers at the Wyss Institute at Harvard University and MIT have created a low-cost, CRISPR-based diagnostic platform that can detect SARS-CoV-2 variants in a patient’s saliva without the need for any additional equipment. The team hopes their device will enable more... -
Video/AnimationBeating Back the Coronavirus – COVID-19 detecting face maskUsing freeze-dried cell free reactions and CRISPR-based biosensors, researchers at the Wyss Institute and M.I.T. have created a face mask that can detect the SARS-CoV-2 virus in a wearer’s breath in under 90 minutes. Such a mask would allow medical professionals to quickly identify COVID-19 patients and begin effective treatments. This facemask is a proof-of-concept... -
Video/AnimationWearable Synthetic Biology – Clothing that can detect pathogens and toxinsWhat if we could create clothing that harnesses synthetic biology to detect the wearer’s exposure to toxins and pathogens? A team of researchers at the Wyss Institute and M.I.T. did just that byembedding freeze-dried, synthetic biology-based sensors into flexible materials and textiles. These sensors can detect pathogens such as the SARS-CoV-2 virus and toxins such... -
Audio/PodcastHarnessing the Power of Artificial Intelligence & Synthetic Biology To Usher In A New Age of Drug Discovery: Jim Collins3 Takeaways features intimate conversations and insights from the world’s best thinkers, business leaders, writers, politicians, scientists, and other newsmakers. Each episode ends with the 3 key takeaways the leading figure has learned over their career. It’s hosted by Lynn Thoman. James Collins, Wyss Core Faculty member and co-inventor of the technology behind Covid vaccines,...
Events 9
-
Sep 20, 2019, 8:20am - 6:00pmWyss Event
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
The 10th International Wyss Institute Symposium will focus on Next-Generation Diagnostics; convening the Institute’s vast network of collaborators, students, researchers, faculty and clinicians alongside industrial researchers, and members of academic institutions and foundations leading the development of diagnostics technology. This year’s Symposium will highlight the latest developments of this emerging field and address the need... Free and open to public -
Jun 3, 2019, 1:00pm - 2:00pmLecture
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Wyss Core Faculty member James J. Collins will be speaking at a Brigham and Women’s Pathology Grand Rounds event on Monday, June 3 from 1 PM to 2 PM. The topic is, “Point of care diagnostics based on synthetic biology.” Accreditation Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education... Free and open to public -
Feb 26, 2019, 1:00pm - 2:00pmLecture
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
On Tuesday, February 26, join Brigham and Women’s Hospital for the weekly Clinical Pathology Conference lecture series featuring Wyss Core Faculty member James Collins. James Collins is a founder of the field of synthetic biology and a pioneer in the application of systems biology concepts to solve major biomedical problems. His internationally acclaimed research uses network... Free and open to public